OSP News

Blue Cross Complete Announces Removal of Pharmacy Copays for Human Immunodeficiency Virus Prevention Drugs

Posted: 10/24/2025

Effective November 1, 2025, no pharmacy copayment will be charged to members for prescription drugs used to help prevent Human Immunodeficiency Virus (HIV) infections. This update applies to HIV prevention drugs pre-exposure prophylaxis, or PrEP and HIV post-exposure prophylaxis, or PEP. 

The Michigan Department of Health and Human Services (MDHHS) issued Bulletin MMP 25-44 on September 30, 2025, designed to remove financial barriers to these type of drugs, increase access to care, and support Michigan’s Equitable Plan, aimed at reducing HIV infections. The Michigan’s Equitable Plan is an effort to reduce new HIV infections by 90% by 2030 through increased diagnosis, treatment, prevention and coordinated response.

Click here to read the full announcement from Blue Cross Complete.

We value your privacy. We use cookies and other technologies to keep the web site reliable and secure, tailor your experience, and measure web site performance, as described in our Privacy Policy.

x

OSP Technical Support